Big-Pharma Novartis to Charge $475,000 for $20,000 Cancer Cure Funded by Taxpayers and Charity

August 31, 2017 (Tony Cartalucci - LD) While Americans squabble over irrelevant political diversions, a revolutionary breakthrough in human healthcare has yielded its first FDA approval - a therapy that literally cures otherwise incurable leukemia.

It is the first of many therapies that re-engineer human cells in living patients to reprogram more resilient immune systems and even repair damaged or aging organs.What would seem like headline news has instead squeaked through as a whimper - not because it is insignificant - but because of how this monumental breakthrough has been hijacked by special interests and how these interests plan on making Americans pay twice for its development behind a smokescreen of public ignorance.

Thanks to a media focused more on dividing and distracting Americans regarding irrelevant political charades, due diligence in researching the story was either sidestepped intentionally, or a result of unprofessional and incompetent journalism. Read More